GG

Guido Guidi

Director at Genenta Science

Guido Guidi has 35 years’ experience in the pharmaceutical industry. He was previously Head of Pharma Europe and Head of Oncology Europe at Novartis, where he was responsible for bringing various drugs from clinical development to market including Cosentryx, Entresto, Lucentis, Gilenya, Xolair, Ultibro, Sandostatin, Femara, Glivec and Jiakavi. While at Novartis, Guido originated and chaired the first edition of Bioupper, the Novartis accelerator for early-stage projects in Italy. He was also Chairman of the Novartis European Executive Committee and a member of the Innovation Management Board responsible for the Pharma division’s R&D program. He has also held different medical positions within Novartis, Sandoz, Roussel-UCLAF and GSK. Guido is currently Chairman and Co-Founder of the investment company AurorA Science.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Genenta Science

Genenta Science is a biotechnology company that develops gene transfer therapy for the treatment of cancer tumors.


Headquarters

Milano, Italy

Employees

1-10

Links